Our Expertise

GLP-1 & Metabolic Health

1 in 8 U.S. adults has already used a GLP-1 medication

We understand the human, clinical, and commercial dynamics reshaping obesity and metabolic care.

Human Understanding

We understand that for people living with chronic and fluctuating disease, treatment value extends far beyond symptom control. Quality of life, treatment burden, confidence, convenience, and the ability to live beyond disease increasingly shape expectations and choices.

Clinical Understanding

We know specialists are navigating expanding therapeutic choices, overlapping mechanisms, and evolving treatment goals based on treatment response and continued uncontrolled symptoms - making the question of which therapy is right for which patient increasingly nuanced.

Commercial Perspective

We help brands uncover the human needs that clinical endpoints alone may not reveal, identify meaningful opportunities for differentiation, and establish a distinctive role within mature and highly competitive categories to unlock new ways to engage patients who have normalized poor outcomes.